feed,title,long_url,short_url
Investors,AstraZeneca Stock Jumps As Upbeat Guidance Offsets Mixed Quarterly Report,https://www.investors.com/news/technology/azn-stock-astrazeneca-earnings-q4-2022/,https://da.gd/rmMZa5
Investors,AbbVie Profit Outlook Widely Misses As The U.S. Humira Battle Kicks Off,https://www.investors.com/news/technology/abbvie-stock-abbvie-earnings-q4-2022/,https://da.gd/TSpxGM
